BioDiem's antimicrobial tested as treatment for TB, fungal infections, in US research program

Australian infectious disease therapy and vaccine development company BioDiem Ltd has detailed a new phase of research to assess its novel antimicrobial BDM-I as a treatment for tuberculosis** (TB), and fungal* infections.